Skip to main content
SpringerLink
Log in

A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF

  • Published:
Biotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamsson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666–70.

    PubMed  Google Scholar 

  2. Old LJ. Tumor necrosis factor. Polypeptide mediator net work. Nature (Lond) 1987; 326: 330–1.

    Google Scholar 

  3. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YCE, Mathison J, Ulevitch R, Cerami A. Identity of tumor necrosis factor and the macrophage secreted factor cachectin. Nature (Lond) 1985; 316: 552–4.

    Google Scholar 

  4. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988; 107: 1269–77.

    PubMed  Google Scholar 

  5. Torti FM, Dieckmann B, Beutler B, Cerami A, Ringold GM. A macrophage factor inhibits adipocyte gene expression: anin vitro model of cachexia. Science (Wash DC) 1985; 229: 867–9.

    Google Scholar 

  6. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/-tumor necrosis factor protects mice from lethal effect of endotoxin. Science (Wash DC) 1985; 229: 869–71.

    Google Scholar 

  7. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond) 1987; 330: 662–4.

    Google Scholar 

  8. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 11: 355–7.

    Google Scholar 

  9. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 1987; 166: 1280–9.

    PubMed  Google Scholar 

  10. Peetre C, Gullberg U, Nilsson E, Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cellsin vitro. Relationship to cell surface receptor. J Clin Invest 1986; 78: 1694–700.

    PubMed  Google Scholar 

  11. Wallach D, Holtmann H, Engelmann H, Nophar Y. Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol 1988; 140: 2994–9.

    PubMed  Google Scholar 

  12. Nophar Y, Holtmann H, Ber R, Wallace D. Dominance of resistance to the cytocidal effect of tumour necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. J Immunol 1988; 140: 3456–60.

    PubMed  Google Scholar 

  13. Wallach D, Nophar Y, Aderka D, Israel S, Hahn T, Engelmann H, Holtmann H. Regulation of the response to tumor necrosis factor. In: Bonavida B, Gifford GE, Kirchner H, Old LJ, eds. Tumor necrosis factor/cachectin and related cytokines. Basel: Karger, 1988: 134–47.

    Google Scholar 

  14. Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988; 41: 414–9.

    PubMed  Google Scholar 

  15. Strober W, Waldmann TA. The role of the kidney in the metabolism of plasma proteins. Nephron 1974; 13: 35–66.

    PubMed  Google Scholar 

  16. Liao Z, Grimshaw RS, Rosenstreich DL. Identification of a specific interleukin 1 inhibitor in the urine of febrile patients. Exp Med 1984; 159: 126–36.

    Google Scholar 

  17. Seckinger P, Isaaz S, Dayer JM. A human inhibitor for tumor necrosis factor. J Exp Med 1988; 167: 1511–6.

    PubMed  Google Scholar 

  18. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264; 11974–80.

    PubMed  Google Scholar 

  19. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989; 42: 270–5.

    PubMed  Google Scholar 

  20. Seckinger P, Isaaz S, Dayer JM. Purification and biologic characterization of a specific tumor necrosis factor inhibitor. J Biol Chem 1989; 264: 11966–73.

    PubMed  Google Scholar 

  21. Gullberg U, Lantz M, Nilsson E, Peetre C, Adolf G, Olsson I. Characterization of a relationship between the T-lymphocyte derived differentiation inducing factor (DIF) and lymphotoxin. A common receptor system for DIF, lymphotoxin and tumor necrosis factor downregulated by phorbol diesters. Eur J Haematol 1987; 39: 241–51.

    PubMed  Google Scholar 

  22. Lantz M, Gullberg U, Nilsson E, Olsson I. Characterizationin vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J Clin Invest; in press.

  23. Stauber GB, Aiyer RA, Aggarwal BB. Human tumor necrosis factor-a receptor. Purification by immunoaffinity chromatography and initial characterization. J Biol Chem 1988; 263: 19098–104.

    PubMed  Google Scholar 

  24. Kull FC, Jacobs S, Cuatrecasas P. Cellular receptor for125I-labeled tumor necrosis factor. Specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci 1985; 82: 5756–60.

    PubMed  Google Scholar 

  25. Gullberg U, Lantz M, Nilsson E, Olsson I. Characterization of the receptor for lymphotoxin; in a spontaneous internalization without recycling and ligand-induced downregulation in HL-60 cells. Eur J Cell Biol 1989; 49: 334–40.

    PubMed  Google Scholar 

  26. Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin-2 receptors are released from activated human lymphoid cellsin vitro. J Immunol 1985; 3172–7.

  27. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170: 1409–14.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Lund Hospital, S-221 85, Lund, Sweden

    Inge Olsson, Urban Gullberg, Mikael Lantz & Christina Peetre

Authors
  1. Inge Olsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Urban Gullberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mikael Lantz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christina Peetre
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsson, I., Gullberg, U., Lantz, M. et al. A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF. Biotherapy 3, 159–165 (1991). https://doi.org/10.1007/BF02172088

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02172088

Key words

Search

Navigation